DKSH starts cooperation with GlaxoSmithKline in Hong Kong
Hong Kong, May 13, 2013 - DKSH's Business Unit Healthcare, the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, has successfully signed...
DATATRAK Expands Latin American Presence with New CRO Partner STAT Research
CLEVELAND, May 13, 2013 -- DATATRAK International, Inc. (otcqx:DTRK), a leader in developing cloud-based, unified eClinical� technologies and delivering related services for the clinical trials...
PRA Supports Welsh Economy with Opening of New Facility in Swansea
RALEIGH, N.C. – PRA, a leading clinical research organization (CRO), today announced the official opening of its new facility in Swansea, Wales. The new building, located on the Swansea...
Harlan Laboratories Continues Global Growth with Major Expansion of North American Facilities
INDIANAPOLIS, May 7, 2013 -- Harlan Laboratories, a leading contract research organization and research models and services company, today announced the expansion of its specialty research...
AMRI Announces First Quarter 2013 Results and Raises EPS Guidance for the Year
Total First Quarter Revenue up 11% at $59.4 Million and Adjusted EPS increased to $0.23 ALBANY, N.Y., May 7, 2013 -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the first...
Quintiles Announces Pricing of Initial Public Offering
Stock Expected to Begin Trading on NYSE May 9th RESEARCH TRIANGLE PARK, NC – Quintiles today announced the pricing of its initial public offering of 23,684,210 shares of its common stock at...
Quintiles Announces Pricing of Initial Public Offering
RESEARCH TRIANGLE PARK, NC – Quintiles today announced the pricing of its initial public offering of 23,684,210 shares of its common stock at a price to the public of $40.00 per share. The...
Phlexglobal Announces Partnership with Arkivum
AMERSHAM, England--Phlexglobal, the specialist provider of Trial Master File (TMF) and electronic Trial Master File (eTMF) expertise, solutions and services for the life sciences industry, has...
West Announces First Quarter 2013 Results
EXTON, PA -- 05/02/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2013 and increased its earnings-per-share (EPS) guidance for...
Charles River Laboratories Announces First-Quarter 2013 Results from Continuing Operations
First-Quarter Sales of $291.2 Million First-Quarter GAAP Earnings per Share of $0.53 and Non-GAAP Earnings per Share of $0.69 Updates 2013 Sales Guidance; Reaffirms 2013 EPS Guidance
...
NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION
Sydney, Australia, 6 May, 2013 – Novotech, Australia's largest independent CRO today announced a funding injection from private equity firm Mercury Capital. (www.mercurycapital.com.au)...
TFS acquires US Oncology and Vaccine specialist Beardsworth Consulting Group, Inc.
LUND, Sweden -- On April 26th, 2013, TFS International (TFS) has completed the acquisition of the New Jersey based Oncology and Vaccine specialist Contract Research Organization (CRO), Beardsworth...
Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
-- Raises FY2013 Pro Forma EPS Target to $3.00 to $3.20 -- PRINCETON, N.J. -- Covance Inc. (NYSE: CVD) today reported results for its first quarter ended March 31, 2013. Net revenue was $580...
PAREXEL International Announces Acquisition of HERON Group LTD, a Leading Commercialization Consultancy
Boston, MA, April 30, 2013 – PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced that today the Company acquired all of the outstanding equity...
PAREXEL INTERNATIONAL REPORTS THIRD QUARTER FISCAL YEAR 2013 RESULTS
Service revenue of $454.5 million, up 27.7% year-over-year GAAP operating margin of 8.1% improves sequentially from 7.4% in the second quarter CRS gross margin improves sequentially to 27.9% from...
PGXL and Silicon Biosystems Collaborate to Offer Clinical Research Services Focused on Oncology Genomics
LOUISVILLE, Ky.--PGXL Technologies and Silicon Biosystems, Inc. announced a collaborative partnership to make the highly regarded Silicon Biosystems DEPArray technology available through PGXL...
Ergomed and CEL-SCI Sign Co-Development Agreement for Multikine in Head and Neck Cancer
London,UK April 24, 2013 – Ergomed Clinical Research Ltd. ("Ergomed") today announced the signing of a co-development and revenue sharing agreement with CEL-SCI Corporation (NYSE MKT: CVM) for...
AMRI and Ono Broaden SMARTSOURCING™ Collaboration
New Agreement Extends Drug Discovery and Development Collaboration Between the Companies Albany, NY (April 23, 2013) – AMRI (NASDAQ: AMRI) announced today that it has entered into a new...
Catalent Biologics Announces Official Opening of New Single-Use Biomanufacturing Center of Excellence at BIO International Convention
State-of-the-art cGMP facility quadruples biomanufacturing capacity, extensively utilizes single-use technology for greater flexibility and efficiency SOMERSET, NJ — Catalent Pharma Solutions,...
Biocon delivers a strong performance of 18% Revenue Growth in FY13 driven by an evolving Product Portfolio & Research Services...
Commenting on the results, Chairman and Managing Director, Kiran Mazumdar-Shaw stated, "We are pleased to close fiscal 2013 on a very strong note. The key contributors to growth this fiscal have...
